Brief: Sonnet Biotherapeutics' Proprietary ADC Platform Available For Drug Discovery Partnerships

Sonnet Biotherapeutics Holdings

19/02/2025 15:29

Feb 19 (Reuters) - Sonnet Biotherapeutics Holdings Inc
 SONN.O :
    * SONNET BIOTHERAPEUTICS ANNOUNCES THAT ITS PROPRIETARY
ANTIBODY
DRUG CONJUGATE (ADC) PLATFORM IS AVAILABLE FOR DRUG DISCOVERY
PARTNERSHIPS WITH POTENTIAL FOR PRODUCING MULTIPLE PIPELINE DRUG
CANDIDATES

Source text:  InGNX6BFnLK 
Further company coverage:  SONN.O 

 ((Reuters.Briefs@thomsonreuters.com;))